toxicities associated with ribociclib from monaleesa-3 trial
Published 4 years ago • 403 plays • Length 0:27Download video MP4
Download video MP3
Similar videos
-
5:12
monaleesa-3: ribociclib plus fulvestrant in hr mbc
-
3:09
overall survival results from monaleesa-3 study on ribociclib plus fulvestrant in advanced breas...
-
2:24
potential in the monaleesa-7 and monaleesa-3 trials
-
2:55
practical implications of the monaleesa-3 trial
-
10:15
monaleesa-3 os results: fulvestrant/ribociclib in postmenopausal hr /her2- advanced breast cancer
-
4:28
monaleesa-7: ribociclib in premenopausal women with mbc
-
24:24
palbociclib and letrozole for my metastatic breast cancer
-
7:18
kisqali (ribociclib): side effects and what to expect
-
12:23
chemotherapy plans | lobular breast cancer
-
1:19
dr. slamon on os results of the monaleesa-3 trial in hr /her2- breast cancer
-
6:44
cdk4/6 inhibitor ribociclib plus fulvestrant improves overall survival in postmenopausal hr-posi...
-
6:44
overall survival (os) results of the phase iii monaleesa-3 trial
-
7:00
ribociclib and endocrine therapy improves survival for pre-menopausal women with advanced breast...
-
3:40
monaleesa-7: results from phase iii trial looking at ribociclib as an addition to endocrine ther...
-
2:49
safety and efficacy of ribociclib and letrozole in advanced breast cancer – the monaleesa-2 trial
-
7:14
ribociclib for hr advanced breast cancer
-
2:00
ribociclib in early breast cancer | nejm
-
13:53
gs2-01: "overall survival subgroup analysis by metastatic site from the phase3 monaleesa-2..."
-
4:48
fda approves ribociclib (kisqali) for stage 2-3 hr /her2- breast cancer at higher risk of recurrence
-
1:19
monaleesa-2: improved os seen in hr advanced breast cancer treated with ribociclib letrozole
-
4:11
ribociclib plus endocrine therapy improves survival in premenopausal patients with metastatic br...
-
7:21
fda approval of ribociclib for metastatic breast cancer